Cargando…

The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences

Coronavirus disease 2019 (COVID-19) is a highly infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory findings from a significant number of patients with COVID-19 indicate the occurrence of leukocytopenia, specifically lymphocytopenia. Moreover,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshammary, Amal F., Al-Sulaiman, Abdulrahman M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276660/ https://www.ncbi.nlm.nih.gov/pubmed/34251989 http://dx.doi.org/10.1080/21505594.2021.1929800

Ejemplares similares

SARS-CoV-2 and the host-immune response
por: Maison, David P., et al.
Publicado: (2023)

From Pandemicity to Endemicity: The Journey of SARS-CoV-2
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

Host Immune Response Driving SARS-CoV-2 Evolution
por: Wang, Rui, et al.
Publicado: (2020)

The journey of antimalarial drugs against SARS-CoV-2: Review article
por: Sarhan, Amany A., et al.
Publicado: (2021)

Immune modulation as a consequence of SARS-CoV-2 infection
por: Gelmez, Metin Yusuf, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs
por: Mekawy, Asmaa S., et al.
Publicado: (2022)

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
por: Weigang, Sebastian, et al.
Publicado: (2021)

Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection
por: Kumar, Swatantra, et al.
Publicado: (2020)

SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
por: Shivshankar, Pooja, et al.
Publicado: (2022)

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Delayed Immune Reconstitution Inflammatory Syndrome in an Immunosuppressed Patient With SARS-CoV-2
por: Garcia-Carretero, Rafael, et al.
Publicado: (2021)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
por: Plasencia-Rodríguez, Chamaida, et al.
Publicado: (2023)

Landscapes of SARS-CoV-2-reactive CD8(+) T cells: heterogeneity of host immune responses against SARS-CoV-2
por: Koh, June-Young, et al.
Publicado: (2021)

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
por: Higgins, Peter D R, et al.
Publicado: (2020)

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
por: Ward, Daniel, et al.
Publicado: (2022)

The roles of lipids in SARS-CoV-2 viral replication and the host immune response
por: Theken, Katherine N., et al.
Publicado: (2021)

Genetic Variants and Protective Immunity against SARS-CoV-2
por: Rabaan, Ali A., et al.
Publicado: (2022)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation
por: Kim, Hye-Jin, et al.
Publicado: (2022)

SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis
por: Kirchner, Theresa, et al.
Publicado: (2021)

Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2
por: Pérez-Lago, Laura, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2
por: Alturaiki, Wael, et al.
Publicado: (2021)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management
por: Mihaescu, Grigore, et al.
Publicado: (2020)

Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
por: Nguyen, Long Chi, et al.
Publicado: (2021)

Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
por: Fintelman-Rodrigues, Natalia, et al.
Publicado: (2021)

Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis
por: Singh, Lakhveer, et al.
Publicado: (2021)

An immunosuppressed Syrian golden hamster model for SARS-CoV infection
por: Schaecher, Scott R., et al.
Publicado: (2008)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
por: Lee, Jee-Soo, et al.
Publicado: (2022)

Mycotic clival osteomyelitis secondary to immunosuppression by SARS-CoV-2
por: Delgado-Arce, Julio César, et al.
Publicado: (2022)

Immunosuppression as a Hub for SARS-CoV-2 Mutational Drift
por: Shapira, Guy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_525kslqj7jfbp7ao5uh8ovnsca